{"url_path":"/sec/apus/8-k/2026-09-11/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry into a Material Definitive Agreement.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-09-11","source_url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-099002-index.html","accession_number":"0001213900-26-099002","cik":"0001894525","ticker":"APUS","issuer_name":"Apimeds Pharmaceuticals US, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-099002-index.html","primary_entity_key":"0001894525","primary_entity_name":"Apimeds Pharmaceuticals US, Inc."},"word_count":287,"has_tables":true,"body_markdown":"**Item 1.01 Entry into a Material Definitive Agreement.**\n\n \n\nOn September 10, 2026, Apimeds Pharmaceuticals\nUS, Inc., a Delaware corporation (the “**Company**”), MindWave Innovations Inc, a Delaware corporation and a wholly owned\nsubsidiary of the Company, Erik Emerson, Lokahi Therapeutics, Inc., a Nevada corporation, FreeT Inc., a company organized under the laws\nof the Republic of Korea (f/k/a Inscobee Inc.) (“**FreeT**”), and Apimeds Inc., a South Korean corporation and wholly owned\nsubsidiary of FreeT (together with FreeT, the “**Inscobee Parties**”), entered into the First Amendment to Confidential\nSettlement and Mutual Release Agreement (the “**Amendment**”), which amends the Confidential Settlement and Mutual Release\nAgreement, dated April 24, 2026 (the “**Settlement Agreement**”), among the Company, MindWave Innovations Inc, Lokahi Therapeutics,\nInc., Erik Emerson, Inscobee Inc. (n/k/a FreeT Inc.), and Apimeds Inc.\n\n \n\nThe Amendment amends Section 10(a) of the Settlement\nAgreement to restructure the composition of the Company’s board of directors (the “**Board**”). During the interim\nperiod between the effective date of the Settlement Agreement and the Preferred Stock Conversion (as defined in the Settlement Agreement),\nthe Board shall consist solely of Elona Kogan, Carol O’Donnell, Dr. Bennett Weintraub, and Sungjoon Chae, none of whom may be removed\nwithout the written consent of Dr. Vin Menon (“**Menon**”) and the Inscobee Parties. Following such interim period, the\nBoard shall consist of seven members: four independent directors nominated by MindWave, two directors nominated by Menon (one of whom\nshall be Menon), and Sungjoon Chae.\n\n \n\nThe foregoing description of the Amendment does\nnot purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as\nExhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference."}